| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |